• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS RUBELLA IGM; RUBELLA VIRUS IMMUNOGLOBULIN M (IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS RUBELLA IGM; RUBELLA VIRUS IMMUNOGLOBULIN M (IGM) Back to Search Results
Catalog Number 07027796190
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/29/2021
Event Type  malfunction  
Manufacturer Narrative
The calibration and qc results were within range.Sample from the patient was received for further investigation and the customer's results were reproduced.The sample was tested on an e801 module: rubella igm result with reagent lot 523730 was 0.773 coi (non reactive).Rubella igg result with reagent lot 533269 was 16 iu/ml (reactive).A general reagent issue was excluded and no product problem was found.The investigation is ongoing.
 
Event Description
There was an allegation of a questionable elecsys rubella igm immunoassay result from cobas e801 module serial number (b)(4).On (b)(6) 2021, the elecsys rubella igm result was 0.599 coi (non-reactive).On (b)(6) 2021, the elecsys rubella igm result was 0.598 coi (non-reactive).On (b)(6) 2021, the elecsys rubella igm result was 0.617 coi (non-reactive).On (b)(6)2021, the result from another laboratory by elisa method was positive.All results were from the same patient sample.It was not known if any questionable result was reported outside of the laboratory.
 
Manufacturer Narrative
The investigation determined the results provide evidence that the correct result for the sample was likely positive for rubella igm.The results are consistent with a fresh infection of the patient.Per product labeling, specimens taken very early in the acute phase of infection may not contain detectable amounts of rubella igm antibodies.It was determined there was no malfunction of the reagent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS RUBELLA IGM
Type of Device
RUBELLA VIRUS IMMUNOGLOBULIN M (IGM)
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key12712203
MDR Text Key278826030
Report Number1823260-2021-03151
Device Sequence Number1
Product Code LFX
UDI-Device Identifier04015630940257
UDI-Public04015630940257
Combination Product (y/n)N
Reporter Country CodeCO
PMA/PMN Number
K092322
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/28/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Catalogue Number07027796190
Device Lot Number523730
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/11/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-